CCL2 and glioblastoma: In addition, CCL2, a chemokine secreted by tumor cells and stromal cells, mediates the recruitment of monocytes and neutrophils, which verified that blocking CCL2 can reduce the percentage of glioblastoma migration (Chen et al. 2022).